GE HealthCare Technologies Inc.
GEHC Healthcare Medical Devices
GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024. In the quarter to June 2026, revenue grew 5.75%, EPS grew 17.0%, free cash flow grew 750.0% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for three consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow GEHC
GE HealthCare Technologies Inc. (GEHC) Revenue
GE HealthCare Technologies Inc.'s revenue for fiscal 2025 was $20.6B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $21.3B. Over the past ten years it has ranged from $16.6B (fiscal 2019) to $20.6B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 6 consecutive fiscal years. GE HealthCare Technologies Inc. ranks 4th of 140 Medical Devices companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $20.6B | 4.84% |
| FY2024 | $19.7B | 0.61% |
| FY2023 | $19.6B | 6.60% |
| FY2022 | $18.3B | 4.30% |
| FY2021 | $17.6B | 2.45% |
| FY2020 | $17.2B | 3.19% |
| FY2019 | $16.6B | — |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jun 2026 | $5.3B | 3.20% |
| Mar 2026 | $5.1B | (9.95%) |
| Dec 2025 | $5.7B | 10.79% |
| Sep 2025 | $5.1B | 2.72% |
| 14 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| GEHC GE HealthCare Technologies Inc. | $21.3B |
| BSX Boston Scientific Corporation compare | $21.0B |
| PHG Koninklijke Philips N.V. compare | $20.6B |
| SNN Smith & Nephew SNATS, Inc. compare | $10.5B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $8.5B |
| EW Edwards Lifesciences Corporation compare | $6.5B |
| STE STERIS plc compare | $6.0B |
| DXCM DexCom, Inc. compare | $5.0B |
| PEN Penumbra, Inc. compare | $1.5B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on GEHC
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement